Canadian Consortium on Neurodegeneration in Aging
Sylvie Belleville is a highly experienced professional in the field of neuropsychology and healthy aging. As the Director of the Consortium Québécois pour l’identification précoce de la maladie d'Alzheimer (CIMA-Q) since 2015 and Team Leader for Team 10 - Cognitive Intervention and Brain Plasticity at the Consortium canadien en neurodégénérescence associée au vieillissement since 2014, Sylvie has contributed significantly to research and intervention strategies for cognitive health. Additionally, as a Founding Member of the Centre AvantÂge, established in 2012, Sylvie has promoted healthy aging initiatives. Sylvie has been the Scientific Director at the Institut universitaire de gériatrie de Montréal (IUGM) et son Centre de recherche since March 2009 and has held a Full Professor position at the Université de Montréal since June 1991. Sylvie's academic foundation includes a Ph.D. in neuropsychology from McGill University and prior degrees in clinical psychology and psychology from Université du Québec à Trois-Rivières.
This person is not in any teams
Canadian Consortium on Neurodegeneration in Aging
What is the CCNA? 350+ clinicians and researchers throughout Canada have come together to form the CCNA and are accelerating progress in age-related neurodegenerative diseases, including Alzheimer’s disease, Vascular dementia, Frontotemporal dementia, and Lewy body dementia. Based on their area of specialization, CCNA’s researchers are divided into 20 teams throughout Canada, and are working in the areas of prevention, treatment, and quality of life. They draw on the data of eight national platforms, and are supported by four cross-cutting programs, who assist teams in identifying gaps, synergies, and accelerating idea uptake. @ccna_ccnv https://vimeo.com/channels/ccna